Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
4
67%
Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
4(66.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(1)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (66.7%)
N/A2 (33.3%)

Trials by Status

completed117%
unknown467%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
unknownphase_3

A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients

NCT01687465
completednot_applicable

Response to SLT vs. ALT in Patients Under 60 Years of Age

NCT01087684
unknownphase_3

Advanced Glaucoma Intervention Study (AGIS)

NCT00000148
terminatednot_applicable

The Canadian Glaucoma Study

NCT00262626
unknownphase_3

Collaborative Initial Glaucoma Treatment Study (CIGTS)

NCT00000149
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01687465Phase 3

A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients

Unknown
NCT01087684Not Applicable

Response to SLT vs. ALT in Patients Under 60 Years of Age

Completed
NCT00000148Phase 3

Advanced Glaucoma Intervention Study (AGIS)

Unknown
NCT00262626Not Applicable

The Canadian Glaucoma Study

Terminated
NCT00000149Phase 3

Collaborative Initial Glaucoma Treatment Study (CIGTS)

Unknown
NCT00000132Phase 3

Early Manifest Glaucoma Trial (EMGT)

Unknown

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6